Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,399 | 275 | 99.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14.47 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $473.06 | 46 | $0 (2018) |
| Biogen, Inc. | $249.75 | 24 | $0 (2023) |
| UCB, Inc. | $238.65 | 22 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $179.49 | 11 | $0 (2023) |
| GENZYME CORPORATION | $177.38 | 12 | $0 (2018) |
| Supernus Pharmaceuticals, Inc. | $162.48 | 12 | $0 (2018) |
| EMD Serono, Inc. | $155.85 | 25 | $0 (2018) |
| Allergan Inc. | $129.24 | 14 | $0 (2017) |
| Bayer HealthCare Pharmaceuticals Inc. | $126.21 | 9 | $0 (2018) |
| Eisai Inc. | $114.71 | 8 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $72.75 | 4 | TG Therapeutics, Inc. ($72.75) |
| 2023 | $67.47 | 3 | Novartis Pharmaceuticals Corporation ($39.78) |
| 2021 | $17.65 | 1 | AbbVie Inc. ($17.65) |
| 2019 | $17.71 | 1 | Genentech USA, Inc. ($17.71) |
| 2018 | $426.28 | 28 | Biogen, Inc. ($56.18) |
| 2017 | $2,811 | 239 | Sunovion Pharmaceuticals Inc. ($443.73) |
All Payment Transactions
276 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/08/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Immunology | ||||||
| 08/12/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Immunology | ||||||
| 08/02/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Immunology | ||||||
| 02/16/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: Immunology | ||||||
| 11/13/2023 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $27.69 | General |
| Category: Neurology | ||||||
| 11/01/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Neurology | ||||||
| 09/19/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Neurology | ||||||
| 04/02/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2019 | Genentech USA, Inc. | Activase (Biological) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Metabolism & Primary Care | ||||||
| 07/30/2018 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $14.39 | General |
| Category: AED | ||||||
| 06/20/2018 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Neuroscience | ||||||
| 06/19/2018 | Biogen, Inc. | TYSABRI (Biological), TECFIDERA | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: NEUROLOGY | ||||||
| 06/15/2018 | Lundbeck LLC | NORTHERA (Drug) | Food and Beverage | Cash or cash equivalent | $14.71 | General |
| Category: NEUROLOGY | ||||||
| 06/13/2018 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $14.92 | General |
| Category: AED | ||||||
| 06/08/2018 | US WorldMeds, LLC | Xadago (Drug), APOKYN, MYOBLOC | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: Neurology | ||||||
| 05/29/2018 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: Neuroscience | ||||||
| 05/23/2018 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 05/18/2018 | AbbVie, Inc. | Duopa (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Neuroscience | ||||||
| 05/16/2018 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $10.38 | General |
| Category: CNS | ||||||
| 05/14/2018 | Mitsubishi Tanabe Pharma America, Inc. | Radicava (Drug) | Food and Beverage | Cash or cash equivalent | $14.96 | General |
| Category: Amyotrophic Lateral Sclerosis | ||||||
| 05/09/2018 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: NEUROLOGY | ||||||
| 04/25/2018 | Biogen, Inc. | TYSABRI (Biological), TECFIDERA | Food and Beverage | In-kind items and services | $10.60 | General |
| Category: NEUROLOGY | ||||||
| 04/21/2018 | Lundbeck LLC | NORTHERA (Drug) | Food and Beverage | Cash or cash equivalent | $21.42 | General |
| Category: NEUROLOGY | ||||||
| 04/18/2018 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: NEUROSCIENCE | ||||||
| 04/09/2018 | EMD Serono, Inc. | Rebif (Biological) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 609 | 6,508 | $282,638 | $84,562 |
| 2022 | 11 | 561 | 5,820 | $255,308 | $80,917 |
| 2021 | 9 | 413 | 457 | $159,909 | $48,195 |
| 2020 | 10 | 410 | 489 | $83,140 | $27,361 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 12 | 5,845 | $70,311 | $28,986 | 41.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 224 | 224 | $95,200 | $24,289 | 25.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 156 | 184 | $42,688 | $10,995 | 25.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 63 | 71 | $23,430 | $5,602 | 23.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 28 | 28 | $12,908 | $3,391 | 26.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 23 | 23 | $12,903 | $3,244 | 25.1% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 12 | 29 | $11,078 | $3,097 | 28.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 12 | 24 | $6,360 | $1,801 | 28.3% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 39 | 40 | $3,880 | $1,631 | 42.0% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 40 | 40 | $3,880 | $1,525 | 39.3% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 11 | 5,200 | $47,616 | $24,532 | 51.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 194 | 194 | $82,450 | $22,572 | 27.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 153 | 180 | $41,760 | $11,359 | 27.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 61 | 70 | $23,100 | $5,870 | 25.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 40 | 40 | $22,440 | $5,806 | 25.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 19 | 38 | $10,070 | $2,892 | 28.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 21 | 21 | $9,681 | $2,634 | 27.2% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 11 | 26 | $9,932 | $2,480 | 25.0% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 12 | 12 | $4,476 | $1,173 | 26.2% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 22 | 22 | $2,134 | $894.45 | 41.9% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 17 | 17 | $1,649 | $705.06 | 42.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 141 | 141 | $59,925 | $17,755 | 29.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 58 | 71 | $23,430 | $7,084 | 30.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 41 | 41 | $23,001 | $6,946 | 30.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 64 | 75 | $17,400 | $5,236 | 30.1% |
About Dr. Kenten Woolhiser, MD
Dr. Kenten Woolhiser, MD is a Neurology healthcare provider based in Salem, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1669470670.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenten Woolhiser, MD has received a total of $3,413 in payments from pharmaceutical and medical device companies, with $72.75 received in 2024. These payments were reported across 276 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($3,399).
As a Medicare-enrolled provider, Woolhiser has provided services to 1,993 Medicare beneficiaries, totaling 13,274 services with total Medicare billing of $241,035. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Salem, OR
- Active Since 07/13/2005
- Last Updated 01/14/2019
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1669470670
Products in Payments
- APTIOM (Drug) $473.06
- AUBAGIO (Drug) $177.38
- Rebif (Biological) $155.85
- VNS Therapy (Device) $145.09
- Vimpat (Drug) $132.13
- Betaseron (Drug) $126.21
- GILENYA (Drug) $123.13
- TYSABRI (Biological) $120.49
- Fycompa (Drug) $114.71
- NUPLAZID (Drug) $109.98
- TECFIDERA (Drug) $106.96
- NAMZARIC (Drug) $104.00
- OXTELLAR XR (Drug) $85.44
- LYRICA (Drug) $77.47
- RYTARY (Drug) $72.88
- BRIUMVI (Drug) $72.75
- TROKENDI XR (Drug) $66.93
- NUEDEXTA (Drug) $65.08
- Xyrem (Drug) $64.94
- ACTIVA (Device) $62.69
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Salem
Timothy Hormel, Md, MD
Neurology — Payments: $92,423
Dr. Keifong Seeto, Md, MD
Neurology — Payments: $19,702
Chaohua Yan, M.d, M.D
Neurology — Payments: $8,800
Daniel Chen, Md, MD
Neurology — Payments: $4,944
Seymur Gahramanov, M.d, M.D
Neurology — Payments: $4,684
Dr. Clement Elechi, M.d, M.D
Neurology — Payments: $3,916